12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sun, 24 Aug 2025 18:22:31 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => X-Frame-Options: SAMEORIGIN [10] => X-Xss-Protection: 1; mode=block [11] => X-Content-Type-Options: nosniff [12] => Referrer-Policy: no-referrer-when-downgrade [13] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=GO6IMKVQSpfhjk1bqYUC5kp%2BtY5%2Fri8pkFm4N9vWfInsYn7OgvsmL7dlcIk7tl5W%2BJjIwvqKFZlb0Z1Xt3p32vS4Dl3aQl%2B2q49VEW0%3D"}]} [14] => Cf-Cache-Status: DYNAMIC [15] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [16] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=5 [17] => Set-Cookie: UpalLiveSession=eyJpdiI6ImNyb09vWTM1Z3p6c1wvdGQ5eFlLR0R3PT0iLCJ2YWx1ZSI6IlF1QU9zWVN4dVdZZmZhcDRYQ0ZuRWNvWXN5M1JxWlA5WUVqV1ZScVAwbWpIYmNVSDVCcVQ4dTBaRnlFb2p0cmlrT3I3aXVNNzJSdDBRTlk1Nm1NVld3PT0iLCJtYWMiOiJkOTRiZjUzZTUxY2Q1YzZkZmNjYzc0N2FhM2I3NTcxNDQ0OTJmN2E1MjljNzZhNWIwOWIxODc1MmRhZTQ3ZGI1In0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Wed, 23 Aug 2028 18:19:23 GMT [18] => CF-RAY: 9744e0271cc697ba-KUL [19] => alt-svc: h3=":443"; ma=86400 ) 789

由中国广东省内专家研制、针对新冠肺炎的中成药“肺炎一号”，于周四正式委托药厂量产，药厂预料下周可以陆续出货，供应予省内各医院使用。但该款新药属于医院制剂，根据规定，它只能在已申报的医院内部使用，一般市民暂时无法购买。

据当地媒体报道，该款新药由5味药材制成，配方并未公开，在周二已获得省药品监督管理局优先审批通过，由广东一方制药有限公司生产。按目前公布的资料，该药有效期为半年，仅对轻症患者有治疗功效，并无预防作用，非确诊者毋须服用。，

省药品监管局早前曾进行临床试验，供广州市第八人民医院的50名轻症患者临床服用该款新药，结果50%患者的咳嗽症状消失、52.4%的咽痛症状消失、69.6%的乏力症状消失，整体症状明显好转，具较好的临床价值。